MycBP2-AS1: A Potential Drug Target and Biomarker (G100874212)

Target Name: MYCBP2-AS1

NCBI ID: G100874212

MYCBP2-AS1

Other Name(s): MYCBP2 antisense RNA 1

MycBP2-AS1: A Potential Drug Target and Biomarker

MycBP2-AS1, also known as MCP2-AS1, is a protein that is expressed in various tissues of the body, including the brain, lungs, heart, and gastrointestinal tract. It is a member of the MycBP2 family, which is known for its role in cell signaling and is highly conserved across different species. The identification of MycBP2-AS1 as a potential drug target and biomarker has significant implications for the development of new therapeutic approaches for various diseases.

MycBP2-AS1 functions as a negative regulator of the Wnt signaling pathway, which is a critical pathway involved in cell proliferation, differentiation, and survival. The Wnt signaling pathway is known to play a crucial role in the development and maintenance of tissues and organs, including the brain. Therefore, alterations in the Wnt signaling pathway have been implicated in a wide range of neurodevelopmental and neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

MycBP2-AS1 is known to regulate the activity of the Wnt signaling pathway by interacting with the protein 尾-catenin. 尾-catenin is a key component of the Wnt signaling pathway and is involved in the regulation of cell proliferation and survival. MycBP2-AS1 has been shown to physically interact with 尾-catenin and prevent its phosphorylation, which is a critical step in the Wnt signaling pathway. This interaction between MycBP2-AS1 and 尾-catenin highlights the importance of MycBP2-AS1 as a potential drug target and biomarker for diseases associated with alterations in the Wnt signaling pathway.

In addition to its role in regulating the Wnt signaling pathway, MycBP2-AS1 has also been shown to play a role in cell signaling and tissue homeostasis. MycBP2-AS1 is involved in the regulation of cell adhesion, migration, and invasion, as well as in the regulation of cell survival and proliferation. These functions are critical for the development and maintenance of tissues and organs, including the brain.

MycBP2-AS1 has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. This is important for the development of new blood vessels, which are critical for delivering oxygen and nutrients to the brain and other organs. The regulation of angiogenesis by MycBP2-AS1 is also important for the treatment of various diseases, including cancer and cardiovascular disease.

In conclusion, MycBP2-AS1 is a protein that is expressed in various tissues of the body and is involved in the regulation of the Wnt signaling pathway, cell signaling, and tissue homeostasis. Its role in these processes makes it a potential drug target and biomarker for diseases associated with alterations in the Wnt signaling pathway. Further research is needed to fully understand the mechanisms of MycBP2-AS1 and its potential as a drug target and biomarker.

Protein Name: MYCBP2 Antisense RNA 1

The "MYCBP2-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MYCBP2-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets